drugset / Trial / NCT01597947
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
Phase 1
Completed
50 enrolled
Achaogen, Inc.
Defense Medical Research and Development Program · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a double-blind, randomized, placebo-controlled, single ascending dose study to assess the safety, tolerability, and PK of ACHN-975 in normal healthy volunteers. This study will take place in the US at one clinical site.
Timeline
- Start
- 2012-05
- Primary completion
- —
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACHN-975 | Small molecule | — | Intravenous |
Indications
No indication recorded.